← Open Payments lookup

FRANK CHEN: Open Payments

NPI 1932294584 · HOUSTON, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$359,008 in 382 payments from 12 companies in 2025. Trend: 2023 $173,928 · 2024 $149,065 · 2025 $359,008

Speaker / faculty: $292,953Travel & lodging: $25,145Honoraria: $16,000Consulting: $15,746Food & beverage: $9,164
CompanyPaymentsAmount
Teva Pharmaceuticals USA, Inc.87$112,822
E.R. Squibb & Sons, L.L.C.111$106,376
Alkermes, Inc.118$85,685
Otsuka America Pharmaceutical, Inc.29$27,915
Luye Pharma (USA) Ltd.20$18,463
Eli Lilly and Company2$7,300
Otsuka Pharmaceutical Development & Commercialization, Inc.5$222
ABBVIE INC.3$66
Axsome Therapeutics, Inc.3$63
Vanda Pharmaceuticals Inc.2$44

Products named: UZEDY, COBENFY, LYBALVI, ABILIFY MAINTENA, ERZOFRI EXTENDED-RELEASE, ARISTADA, REJOYN, VRAYLAR.

Industry payments across TX — which companies pay providers there.